Literature DB >> 11433215

NO, nitrotyrosine, and cyclic GMP in signal transduction.

K A Hanafy1, J S Krumenacker, F Murad.   

Abstract

Over the past 25 years, the role of nitric oxide (NO) in biology has evolved from being recognized as an environmental pollutant to an endogenously produced substance involved in cell communication and signal transduction. NO is produced by a family of enzymes called nitric oxide synthases (NOSs), which can be stimulated by a variety of factors that mediate responses to various stimuli. NO can initiate its biological effects through activation of the heterodimeric enzyme, soluble guanylyl cyclase (sGC), or through several other chemical reactions. Activation of sGC results in the production of 3',5'-cyclic guanosine monophosphate (cGMP), an intracellular second messenger signaling molecule, which can subsequently mediate such diverse physiological events such as vasodilatation and immunomodulation. Chemically reactive NO can affect physiological changes through modifications to cellular proteins, one of which is tyrosine nitration. The demonstration that NO is involved in so many biological pathways indicates the importance of this endogenously produced substance, and suggests that there is much more to be discovered about its role in biology in years to come.

Entities:  

Keywords:  NASA Discipline Cardiopulmonary; Non-NASA Center

Mesh:

Substances:

Year:  2001        PMID: 11433215

Source DB:  PubMed          Journal:  Med Sci Monit        ISSN: 1234-1010


  57 in total

1.  Histone H1.2 is a substrate for denitrase, an activity that reduces nitrotyrosine immunoreactivity in proteins.

Authors:  Yasuyuki Irie; Makio Saeki; Yoshinori Kamisaki; Emil Martin; Ferid Murad
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-28       Impact factor: 11.205

2.  S-nitrosylation of cysteine 289 of the AT1 receptor decreases its binding affinity for angiotensin II.

Authors:  Patrice C Leclerc; Pascal M Lanctot; Mannix Auger-Messier; Emanuel Escher; Richard Leduc; Gaetan Guillemette
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

3.  Photo-activity induced by amyloidogenesis.

Authors:  Olga Tcherkasskaya
Journal:  Protein Sci       Date:  2007-02-27       Impact factor: 6.725

4.  Nitric oxide inhibits capacitative Ca2+ entry by suppression of mitochondrial Ca2+ handling.

Authors:  Baskaran Thyagarajan; Roland Malli; Kurt Schmidt; Wolfgang F Graier; Klaus Groschner
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

Review 5.  Antihypertensive medications, bone mineral density, and fractures: a review of old cardiac drugs that provides new insights into osteoporosis.

Authors:  Mahua Ghosh; Sumit R Majumdar
Journal:  Endocrine       Date:  2014-02-07       Impact factor: 3.633

Review 6.  Carbon Monoxide and the brain: time to rethink the dogma.

Authors:  Khalid A Hanafy; Justin Oh; Leo E Otterbein
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

7.  Cyclic GMP acts as a common regulator for the transcriptional activation of the flavonoid biosynthetic pathway in soybean.

Authors:  Kenji Suita; Takaaki Kiryu; Maki Sawada; Maiko Mitsui; Masataka Nakagawa; Kengo Kanamaru; Hiroshi Yamagata
Journal:  Planta       Date:  2008-11-06       Impact factor: 4.116

8.  Molecular bases for the recognition of short peptide substrates and cysteine-directed modifications of human insulin-degrading enzyme.

Authors:  Enrico Malito; Luis A Ralat; Marika Manolopoulou; Julie L Tsay; Natasha L Wadlington; Wei-Jen Tang
Journal:  Biochemistry       Date:  2008-12-02       Impact factor: 3.162

9.  Study of the nitric oxide system in the rat cerebellum during aging.

Authors:  Santos Blanco; Francisco J Molina; Lourdes Castro; Maria L Del Moral; Raquel Hernandez; Ana Jimenez; Alma Rus; Esther Martinez-Lara; Eva Siles; Maria A Peinado
Journal:  BMC Neurosci       Date:  2010-06-24       Impact factor: 3.288

Review 10.  Nitric oxide and cyclic nucleotides: their roles in junction dynamics and spermatogenesis.

Authors:  Nikki P Y Lee; C Yan Cheng
Journal:  Oxid Med Cell Longev       Date:  2008 Oct-Dec       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.